LungLife AI, Inc. (the “Company” or “LungLife”) Total Voting Rights The Company’s total issued share capital consists of 25,485,982 Ordinary Shares of US $0.0001 each ("Ordinary Shares") with one voting right per Ordinary Share. There are no Ordinary Shares held in treasury. The total number of voting rights in the Company is therefore 25,485,982. This […]
15 November 2022 LungLife AI, Inc. ("LungLife" or the "Company") Block Listing Six Monthly Return LungLife AI (AIM: LLAI), a developer of clinical diagnostic solutions for lung cancer, makes the following six-monthly update on its block listing: Name of applicant: LungLife AI, Inc. Name of scheme: 2010 Stock Incentive Plan 2020 Stock […]